IPMP's email address is provided, along with website addresses for general information, enrolling in IPMP, seeking information from the database, and uploading data. Contact information is provided for the Program Information Coordinator and the Executive Director. Statistics for 2017 cover the state population (1,753,860), DEA registered prescribers (8,379), and DEA registered dispensers (323). IPMP available reports are listed. Funding sources for 2018 were licensing fees, controlled substance registration fees, and the regulatory board fund. The staff numbers are reported for the following job categories: operational (1), technical (1), analytical (1), and "other" (2). Key dates for the establishment and implementation of the IPMP are enabling legislation enactment (1967), becoming operational (1967), initial user access (June 1999), on-line access (June 1999), and electronic reporting (204). Access information is provided for statutes and rules relevant to the IPMP's authority and responsibilities. Reporting frequency is the next business day, and reporting is required even when there is nothing to report. The IPMP monitors the controlled substances in schedules II, III, IV, and V, and it has the authority to monitor other substances. It also monitors naloxone dispensing information, and drug manufacturers or distributors data. IPMP reporting is monthly. IPMP enrollment is required for prescribers. Regulations for IPMP accounts pertain to law enforcement requirements, namely, an active investigation and application on-line or by written request. In addition, criteria are specified for requesting information from the IPMP, as well as data retention. Requestor training is required for prescribers, dispensers, law enforcement, the regulatory board, and attorney general. Other information covers interstate data sharing, data integration, and patient matching. Requestor types and the reports each is authorized to create and that are actually produced are noted. formation and data are presented for Idaho's Prescription Monitoring Program (IPMP), which is administered by the Idaho Board of Pharmacy. IPMP's email address is provided, along with website addresses for general information, enrolling in IPMP, seeking information from the database, and uploading data. Contact information is provided for the Program Information Coordinator and the Executive Director. Statistics for 2017 cover the state population (1,753,860), DEA registered prescribers (8,379), and DEA registered dispensers (323). IPMP available reports are listed. Funding sources for 2018 were licensing fees, controlled substance registration fees, and the regulatory board fund. The staff numbers are reported for the following job categories: operational (1), technical (1), analytical (1), and "other" (2). Key dates for the establishment and implementation of the IPMP are enabling legislation enactment (1967), becoming operational (1967), initial user access (June 1999), on-line access (June 1999), and electronic reporting (204). Access information is provided for statutes and rules relevant to the IPMP's authority and responsibilities. Reporting frequency is the next business day, and reporting is required even when there is nothing to report. The IPMP monitors the controlled substances in schedules II, III, IV, and V, and it has the authority to monitor other substances. It also monitors naloxone dispensing information, and drug manufacturers or distributors data. IPMP reporting is monthly. IPMP enrollment is required for prescribers. Regulations for IPMP accounts pertain to law enforcement requirements, namely, an active investigation and application on-line or by written request. In addition, criteria are specified for requesting information from the IPMP, as well as data retention. Requestor training is required for prescribers, dispensers, law enforcement, the regulatory board, and attorney general. Other information covers interstate data sharing, data integration, and patient matching. Requestor types and the reports each is authorized to create and that are actually produced are noted.
Prescription Drug Monitoring Program: Idaho State Profile
NCJ Number
252998
Date Published
August 2018
Length
8 pages
Annotation
Information and data are presented for Idaho's Prescription Monitoring Program (IPMP), which is administered by the Idaho Board of Pharmacy.
Abstract